The importance of specificity of drug treatment in head and neck cancer: current developments in personalized medicine to improve safety and tolerability
The future of HNSCC treatment lies in the development of novel treatment combinations integrating immunotherapy using immune checkpoint blockade with newer therapeutic approaches. Understanding which agents to use, and when in the course of treatment, stands as a challenge that will shape the future of precision therapy for HNSCC, with integration of biomarkers promising to guide this transition.
Authors
- Barbara M. Champlin
- Katherine R. Keefe (ORCID: https://orcid.org/0000-0001-7247-0261)
- Andrew C. Birkeland (ORCID: https://orcid.org/0000-0003-2500-2857)
- Shiruyeh Schokrpur (ORCID: https://orcid.org/0000-0001-9441-9547)
Institutions
- University of California System (US)
Publication Details
- Journal
- Expert Review of Clinical Pharmacology
- Published
- 2025-12-02
- DOI
- https://doi.org/10.1080/17512433.2025.2600408
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00